These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 35057707)

  • 1. D-Chiro-inositol and PCOS: between myth and reality. The never-ending story.
    Cianci A; Vitale SG
    Int J Food Sci Nutr; 2022 Aug; 73(5):565-570. PubMed ID: 35057707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Inositols in the Hyperandrogenic Phenotypes of PCOS: A Re-Reading of Larner's Results.
    Fedeli V; Catizone A; Querqui A; Unfer V; Bizzarri M
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of inositol(s) isomers in the management of polycystic ovary syndrome: a comprehensive review.
    Gateva A; Unfer V; Kamenov Z
    Gynecol Endocrinol; 2018 Jul; 34(7):545-550. PubMed ID: 29309199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy of oral insulin sensitizers metformin, thiazolidinediones, inositol, and berberine in improving endocrine and metabolic profiles in women with PCOS: a network meta-analysis.
    Zhao H; Xing C; Zhang J; He B
    Reprod Health; 2021 Aug; 18(1):171. PubMed ID: 34407851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inositols: From Established Knowledge to Novel Approaches.
    Dinicola S; Unfer V; Facchinetti F; Soulage CO; Greene ND; Bizzarri M; Laganà AS; Chan SY; Bevilacqua A; Pkhaladze L; Benvenga S; Stringaro A; Barbaro D; Appetecchia M; Aragona C; Bezerra Espinola MS; Cantelmi T; Cavalli P; Chiu TT; Copp AJ; D'Anna R; Dewailly D; Di Lorenzo C; Diamanti-Kandarakis E; Hernández Marín I; Hod M; Kamenov Z; Kandaraki E; Monastra G; Montanino Oliva M; Nestler JE; Nordio M; Ozay AC; Papalou O; Porcaro G; Prapas N; Roseff S; Vazquez-Levin M; Vucenik I; Wdowiak A
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between effects of myo-inositol and D-chiro-inositol on ovarian function and metabolic factors in women with PCOS.
    Pizzo A; Laganà AS; Barbaro L
    Gynecol Endocrinol; 2014 Mar; 30(3):205-8. PubMed ID: 24351072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inositols' Importance in the Improvement of the Endocrine-Metabolic Profile in PCOS.
    Wojciechowska A; Osowski A; Jóźwik M; Górecki R; Rynkiewicz A; Wojtkiewicz J
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31752081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on the combination of myo-inositol/d-chiro-inositol for the treatment of polycystic ovary syndrome.
    Lete I; Martínez A; Lasaga I; Centurión E; Vesga A
    Gynecol Endocrinol; 2024 Dec; 40(1):2301554. PubMed ID: 38239032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inositols in PCOS.
    Kamenov Z; Gateva A
    Molecules; 2020 Nov; 25(23):. PubMed ID: 33260918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PCOS and Inositols: Controversial Results and Necessary Clarifications. Basic Differences Between D-Chiro and Myo-Inositol.
    Monastra G; Vucenik I; Harrath AH; Alwasel SH; Kamenov ZA; Laganà AS; Monti N; Fedeli V; Bizzarri M
    Front Endocrinol (Lausanne); 2021; 12():660381. PubMed ID: 33889133
    [No Abstract]   [Full Text] [Related]  

  • 11. Updates on the myo-inositol plus D-chiro-inositol combined therapy in polycystic ovary syndrome.
    Unfer V; Porcaro G
    Expert Rev Clin Pharmacol; 2014 Sep; 7(5):623-31. PubMed ID: 24898153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inositol in Polycystic Ovary Syndrome: Restoring Fertility through a Pathophysiology-Based Approach.
    Laganà AS; Garzon S; Casarin J; Franchi M; Ghezzi F
    Trends Endocrinol Metab; 2018 Nov; 29(11):768-780. PubMed ID: 30270194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myo-inositol vs. D-chiro inositol in PCOS treatment.
    Formuso C; Stracquadanio M; Ciotta L
    Minerva Ginecol; 2015 Aug; 67(4):321-5. PubMed ID: 25670222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myo-inositol in assisted reproductive technology from bench to bedside.
    Etrusco A; Laganà AS; Chiantera V; Buzzaccarini G; Unfer V
    Trends Endocrinol Metab; 2024 Jan; 35(1):74-83. PubMed ID: 37798243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Combined therapy myo-inositol plus D-Chiro-inositol, in a physiological ratio, reduces the cardiovascular risk by improving the lipid profile in PCOS patients.
    Minozzi M; Nordio M; Pajalich R
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17(4):537-40. PubMed ID: 23467955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myo-inositol and D-chiro-inositol (40:1) reverse histological and functional features of polycystic ovary syndrome in a mouse model.
    Bevilacqua A; Dragotto J; Giuliani A; Bizzarri M
    J Cell Physiol; 2019 Jun; 234(6):9387-9398. PubMed ID: 30317628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An innovative approach to polycystic ovary syndrome.
    Bizzarri M; Logoteta P; Monastra G; Laganà AS
    J Obstet Gynaecol; 2022 May; 42(4):546-556. PubMed ID: 34169781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bye-bye chiro-inositol - myo-inositol: true progress in the treatment of polycystic ovary syndrome and ovulation induction.
    Galletta M; Grasso S; Vaiarelli A; Roseff SJ
    Eur Rev Med Pharmacol Sci; 2011 Oct; 15(10):1212-4. PubMed ID: 22165685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining treatment with myo-inositol and D-chiro-inositol (40:1) is effective in restoring ovary function and metabolic balance in PCOS patients.
    Monastra G; Unfer V; Harrath AH; Bizzarri M
    Gynecol Endocrinol; 2017 Jan; 33(1):1-9. PubMed ID: 27898267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relevance of inositols treatment for PCOS before and during ART.
    Artini PG; Malacarne E; Tomatis V; Genazzani AD
    Eur Rev Med Pharmacol Sci; 2021 Jul; 25(14):4799-4809. PubMed ID: 34337729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.